Related Experiment Videos
Regional and systemic CD4 and CD8 subsets in bronchogenic carcinoma
H P Liss1, M A Baumann, C C Paul
1Department of Medicine, Wright State University School of Medicine, Dayton, Ohio.
The Netherlands Journal of Medicine
|December 11, 1991
Summary
Peripheral bronchogenic carcinoma did not alter local lung immunity in asymptomatic patients. However, a decreased CD4/CD8 ratio was observed in peripheral blood, suggesting systemic immune changes potentially linked to cancer, smoking, or COPD.
Area of Science:
- Immunology
- Oncology
- Pulmonology
Background:
- Peripheral bronchogenic carcinoma is a common malignancy.
- Understanding the local and systemic immune response in lung cancer is crucial for treatment strategies.
- Asymptomatic patients may present with subtle immune alterations.
Purpose of the Study:
- To investigate the immune status of lymphocytes in the lungs and blood of patients with peripheral bronchogenic carcinoma.
- To compare the immune cell populations in tumor-involved lung segments versus uninvolved segments.
- To assess the CD4/CD8 ratio in peripheral blood as a potential indicator of systemic immune changes.
Main Methods:
- Bronchoalveolar lavage was performed on tumor-bearing and contralateral lung segments in 12 asymptomatic patients.
- Mononuclear cells were isolated and analyzed using flow cytometry after macrophage depletion.
- Cell surface markers CD4 and CD8 were used to identify T-cell subsets.
Main Results:
- No significant differences were found in mononuclear cell percentages (CD4+, CD8+) between tumor-involved and uninvolved lung segments.
- A statistically significant decrease in the CD4/CD8 ratio was observed in the peripheral blood of patients.
- These findings suggest localized immune stability within the lung parenchyma despite tumor presence.
Conclusions:
- Lung carcinoma does not appear to alter the local immunologic environment within the lung parenchyma.
- The observed depression of the CD4/CD8 ratio in peripheral blood warrants further investigation.
- The specific cause of the peripheral blood immune changes remains unclear and could be attributed to the bronchogenic carcinoma, smoking, or chronic obstructive pulmonary disease (COPD).